Abstract 5203: Discovery and development of SLD2435, a novel humanized IgG1 bispecific antibody simultaneously targeting human TIGIT and PVRIG for cancer immunotherapy
Xiaofeng Zhao(China Pharmaceutical University), Renhong Tang(Nanyang Technological University), Zhenna Gao(China Pharmaceutical University), Ya–Yuan Fu(Memorial Sloan Kettering Cancer Center), Xiaoqing Liu(Fujian Medical University), Yang Liu(Nankai University), Hai Huang(Guangzhou University of Chinese Medicine), Mengyu Wang(Zhengzhou University), Zhuoxiao Cao(China Pharmaceutical University), Fengli Shan(China Pharmaceutical University), Huiming Xu(China Pharmaceutical University), Wenqing Yang(Guangzhou University of Chinese Medicine)
Cited by 0
Related Papers
Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis
|Journal of Hepatology|2021|378
Biomedical polymers: synthesis, properties, and applications
|Science China Chemistry|2022|192
A tough, antibacterial and antioxidant hydrogel dressing accelerates wound healing and suppresses hypertrophic scar formation in infected wounds
|Bioactive Materials|2024|183
Failure of Elastic Fiber Homeostasis Leads to Pelvic Floor Disorders
|American Journal Of Pathology|2006|171